Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology... Show more
EYEN is expected to report earnings to fall 99.51% to -7 cents per share on May 14
Q1'25
Est.
$-0.08
Q4'24
Missed
by $16.35
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.06
Q1'24
Missed
by $0.01
The last earnings report on March 26 showed earnings per share of -1644 cents, missing the estimate of -9 cents. With 37.81K shares outstanding, the current market capitalization sits at 3.09M.